Julie H. McHugh's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 45,000 Class A Common Stock done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 45,000 | 208,839 (0%) | 0% | 0 | Class A Common Stock | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 81.62 per share. | 09 Jun 2025 | 5,192 | 25,962 (0%) | 0% | 81.6 | 423,771 | Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 4,543 | 4,543 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 2,537 | 31,154 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,311 | 163,839 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 10 Jun 2024 | 22,766 | 139,528 (0%) | 0% | 6.3 | 143,198 | Class A Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 78.50 per share. | 28 May 2024 | 2,500 | 28,617 (0%) | 0% | 78.5 | 196,250 | Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 4,853 | 4,853 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,635 | 31,117 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 22,350 | 162,294 (0%) | 0% | 0 | Class A Common Stock | |
| Evelo Biosciences Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 3,798 | 3,798 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 2,012 | 28,482 (0%) | 0% | 0 | Common Stock | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 78.50 per share. | 06 Sep 2022 | 4,300 | 26,470 (0%) | 0% | 78.5 | 337,550 | Common Stock |
| Evelo Biosciences Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,571 | 139,944 (0%) | 0% | 0 | Class A Common Stock | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 57.84 per share. | 11 May 2022 | 2,980 | 30,770 (0%) | 0% | 57.8 | 172,363 | Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 4,068 | 4,068 | - | - | Stock Option (right to buy) | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 11.67 per share. | 14 Mar 2022 | 20,000 | 118,373 (0%) | 0% | 11.7 | 233,400 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 11.02 per share. | 14 Dec 2021 | 10,000 | 138,373 (0%) | 0% | 11.0 | 110,200 | Common Stock |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 22,766 | 148,373 (0%) | 0% | 0 | Class A Common Stock | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 8,513 | 31,570 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 2,500 | 125,607 (0%) | 0% | 0 | Class A Common Stock | |
| Evelo Biosciences Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2021 | 31,380 | 31,380 | - | - | Stock Option (Right to Buy) | |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 21.22 per share. | 09 Apr 2021 | 2,800 | 23,057 (0%) | 0% | 21.2 | 59,416 | Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,259 | 25,857 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | Julie H. McHugh | Director | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 08 Sep 2020 | 7,950 | 123,107 (0%) | 0% | 9.8 | 77,672 | Class A Common Stock |
| Lantheus Holdings Inc | Julie H. McHugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 749 | 24,598 (0%) | 0% | 0 | Common Stock |